Navigation Links
NOTES research activities increase with grants from Olympus medical Systems totaling $1 million
Date:7/9/2008

OAK BROOK, Ill., July 10, 2008 The Natural Orifice Surgery Consortium for Assessment and Research™ (NOSCAR™), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), today announced Olympus' continuing commitment to funding research in an emerging transdisciplinary therapy known as Natural Orifice Translumenal Endoscopic Surgery™ (NOTES™), with a $500,000 grant to the existing Olympus Research Fund supporting NOTES™ research. The grant increases Olympus' total funding to $1 million. NOTES™, which is performed by using the patient's natural openings for surgery, will be discussed among researchers from July 10-12, 2008 at the 3rd International Conference on NOTES™ in San Francisco, Calif.

"The Olympus Research Fund established in 2007 has already supported nine studies producing results that are advancing the understanding and applications of this fascinating and innovative technique," said Haruhito Morishima, president, Olympus Medical Systems Corporation. "As the world's leader in endoscopy, we are proud to continue our support of NOTES™ research, an approach that could ultimately represent a major paradigm shift in minimally invasive therapy."

This fund was established with an initial $500,000 grant from Olympus. Though studies from this grant are ongoing, one of the nine studies that has been completed is expected to be published in two peer-reviewed journals. Researchers will learn more about these studies at the upcoming NOTES™ conference.

"NOTES™ is moving forward more rapidly than initially expected," said Robert H. Hawes, MD, FASGE, ASGE past president and NOSCAR™ Joint Committee co-chair. "Three years ago, we never anticipated the progress in the research arena that has been made in such a short period. Thanks to leaders such as Olympus, we are making great strides in NOTES™ technology."

NOSCAR™ received more than 40 requests for funding from this new Olympus grant. NOSCAR™ will determine the grant recipients in mid-July. A listing of those who received funding will be posted to www.noscar.org.

"We are most grateful to Olympus for its ongoing commitment and vision in supporting NOTES™ research," said David W. Rattner, MD, SAGES past president and NOSCAR™ Joint Committee co-chair.


'/>"/>

Contact: Anne Brownsey
abrownsey@asge.org
630-570-5635
American Society for Gastrointestinal Endoscopy
Source:Eurekalert

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
3. Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
4. Flextronics Announces Redemption and Change of Control Repurchase Offer for Solectron 8.00% Senior Subordinated Notes and Planned Change of Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
5. Flextronics Announces Change in Control Repurchase Offer for Solectrons 0.50% Senior Convertible Notes
6. Vanda Pharmaceuticals Announces that it No Longer Intends to Offer Convertible Senior Notes
7. Providence Service Corporation Completes Private Placement of $70 Million of Convertible Senior Subordinated Notes
8. MediNotes EMR Now Interfaces With 76 Practice Management Systems, Allowing More Medical Practices to Replace Their Patients Aging Paper Medical Records
9. AllerNotes Help Take Food Allergies Off the Table
10. MQ Associates, Inc. Announces Expiration of its Tender Offers for its 12 1/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Medquest, Inc.s 11 7/8% Senior Subordinated Notes Due 2012 (CUSIP No. 58505DAD1)
11. MQ Associates, Inc. Announces Cash Tender Offer for 121/4% Senior Discount Notes Due 2012 (CUSIP No. 55345RAC2) and Related Consent Solicitation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... New SUPRO® XT55 Isolated ... beverages by helping beverage manufacturers more effectively manage protein costs. “Soy protein has ... as well as more stable pricing over time. Now it’s even more relevant ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, a leader in ... a new class of photodynamic cosmetics (PDC). , Allumera® is the first PDC ... signs of aging, and minimize the appearance of pores – all with minimal ...
(Date:4/25/2017)... ... 25, 2017 , ... Coalition Duchenne, a ... muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics on positive ... trial in Duchenne announced today. , Coalition Duchenne funded studies carried out ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... a modern procedure that achieves results in a fraction of the time as ... Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment with or ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... WARSAW, Ind. , April 20, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Health Care Conference at the InterContinental Hotel in ... 2017.  Zimmer Biomet will present at 11:20 a.m. Eastern ... can be accessed via Zimmer Biomet,s Investor Relations website ...
(Date:4/20/2017)... 2017  CVS Pharmacy, the retail division of ... store design to enhance the retail customer experience ... products and expanded beauty selections paired with informational ... new offerings. Together with its innovative digital programs, ... customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
Breaking Medicine Technology: